T cell immunity is central for the control of viral infections. To characterize T cell immunity,
but also for the development of vaccines, identification of exact viral T cell epitopes is …

The pathophysiology of COVID-19–associated thrombosis seems to be multifactorial. We
hypothesized that COVID-19 is accompanied by procoagulant platelets with subsequent …

The humoral immune response to SARS-CoV-2 is a benchmark for immunity and detailed
analysis is required to understand the manifestation and progression of COVID-19, monitor …

Pathogenic Antibodies in Patients with VITT Vaccine-induced immune thrombotic
thrombocytopenia is caused by the induction of anti-PF4 polyanion antibodies in response to the …

Many drugs have been implicated in drug-induced immune thrombocytopenia (DITP). Patients
with DITP develop a drop in platelet count 5 to 10 days after drug administration with an …

Immune thrombocytopenia (ITP) is an autoimmune disorder defined by a significantly reduced
number of platelets in blood circulation. Due to low levels of platelets, ITP is associated …

Several therapeutic agents can cause thrombocytopenia by either immune-mediated or non-immune-mediated
mechanisms. Non-immune-mediated thrombocytopenia is due to direct …

Vaccine administration is under way worldwide to combat the current COVID‐19 pandemic.
The newly developed vaccines are highly effective with minimal adverse effects. Recently, …

Inherited retinal disease is a common cause of visual impairment and represents a highly
heterogeneous group of conditions. Here, we present findings from a cohort of 722 individuals …

SARS-CoV-2 is evolving with mutations in the receptor binding domain (RBD) being of
particular concern. It is important to know how much cross-protection is offered between strains …